Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Push Health vs Sprout Health

Push Health
Graded #419

Lower grade

vs+30.200000000000003
Sprout Health
Graded #6

Higher grade

The verdict

Sprout Health takes it — 86.4/100 to 56.2/100.

Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSprout Health +55
35
90
Dose & formulationSprout Health +17
65
82
Clinical oversightSprout Health +17
71
88
Labs & monitoringSprout Health +40
52
92
FulfillmentSprout Health +11
67
78
Contract termsSprout Health +29
55
84
Push Health · left barSprout Health · right bar

The numbers

MetricPush HealthSprout Health
WeighScore56.2/10086.4/100
GradeCB
Scorecard rank#419#6
Semaglutide$950/mo (brand-name)$149/mo
TirzepatideNot disclosed$199/mo
CoverageCoverage not publishedNot disclosed
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Push Health

Graded #419 · C

Strengths

  • Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
  • 55,000+ pharmacy network per competitor sources
  • LegitScript certified per competitor sources
  • Listed in both competitor directories

Where it loses points

  • Brand-name-only — no compounded option
  • Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
  • Confidence LOW until verified
Sprout Health

Graded #6 · B

Strengths

  • LegitScript-certified with a listed address and contact line
  • Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
  • Low-friction intake — no labs and often no telehealth visit required

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard